187 related articles for article (PubMed ID: 3534051)
1. Physiologic considerations in drug absorption from the gastrointestinal tract.
Golub AL; Frost RW; Betlach CJ; Gonzalez MA
J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 2):689-94. PubMed ID: 3534051
[TBL] [Abstract][Full Text] [Related]
2. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
3. Drug absorption in gastrointestinal disease with particular reference to malabsorption syndromes.
Parsons RL
Clin Pharmacokinet; 1977; 2(1):45-60. PubMed ID: 322910
[TBL] [Abstract][Full Text] [Related]
4. Exploring gastrointestinal variables affecting drug and formulation behavior: Methodologies, challenges and opportunities.
Hens B; Corsetti M; Spiller R; Marciani L; Vanuytsel T; Tack J; Talattof A; Amidon GL; Koziolek M; Weitschies W; Wilson CG; Bennink RJ; Brouwers J; Augustijns P
Int J Pharm; 2017 Mar; 519(1-2):79-97. PubMed ID: 27915009
[TBL] [Abstract][Full Text] [Related]
5. Ethanol-drug absorption interaction: potential for a significant effect on the plasma pharmacokinetics of ethanol vulnerable formulations.
Lennernäs H
Mol Pharm; 2009; 6(5):1429-40. PubMed ID: 19655809
[TBL] [Abstract][Full Text] [Related]
6. The dynamic gastric environment and its impact on drug and formulation behaviour.
Van Den Abeele J; Rubbens J; Brouwers J; Augustijns P
Eur J Pharm Sci; 2017 Jan; 96():207-231. PubMed ID: 27597144
[TBL] [Abstract][Full Text] [Related]
7. Drug dissolution: significance of physicochemical properties and physiological conditions.
Jambhekar SS; Breen PJ
Drug Discov Today; 2013 Dec; 18(23-24):1173-84. PubMed ID: 24042023
[TBL] [Abstract][Full Text] [Related]
8. Drugs, diseases and altered gastric emptying.
Nimmo WS
Clin Pharmacokinet; 1976; 1(3):189-203. PubMed ID: 797497
[TBL] [Abstract][Full Text] [Related]
9. Predictive models for oral drug absorption: from in silico methods to integrated dynamical models.
Dokoumetzidis A; Kalantzi L; Fotaki N
Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):491-505. PubMed ID: 17696801
[TBL] [Abstract][Full Text] [Related]
10. The influence of gastric emptying kinetics on the drug release from enteric coated pellets in fasted state: an in vitro/in vivo correlation.
Stefanič M; Locatelli I; Vrečer F; Sever T; Mrhar A; Bogataj M
Eur J Pharm Biopharm; 2012 Oct; 82(2):376-82. PubMed ID: 22884655
[TBL] [Abstract][Full Text] [Related]
11. Development and applications of a physiologically-based model of paediatric oral drug absorption.
Johnson TN; Bonner JJ; Tucker GT; Turner DB; Jamei M
Eur J Pharm Sci; 2018 Mar; 115():57-67. PubMed ID: 29309876
[TBL] [Abstract][Full Text] [Related]
12. PBPK models for the prediction of in vivo performance of oral dosage forms.
Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
[TBL] [Abstract][Full Text] [Related]
13. Effects of food on the bioavailability of theophylline from controlled-release products in adults.
Karim A
J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 2):695-703. PubMed ID: 3771959
[TBL] [Abstract][Full Text] [Related]
14. Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH.
Charman WN; Porter CJ; Mithani S; Dressman JB
J Pharm Sci; 1997 Mar; 86(3):269-82. PubMed ID: 9050793
[TBL] [Abstract][Full Text] [Related]
15. Simulating the postprandial stomach: physiological considerations for dissolution and release testing.
Koziolek M; Garbacz G; Neumann M; Weitschies W
Mol Pharm; 2013 May; 10(5):1610-22. PubMed ID: 23506381
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical applications of AC biosusceptometry.
Corá LA; Américo MF; Romeiro FG; Oliveira RB; Miranda JR
Eur J Pharm Biopharm; 2010 Jan; 74(1):67-77. PubMed ID: 19482083
[TBL] [Abstract][Full Text] [Related]
17. Role of regional absorption and gastrointestinal motility on variability in oral absorption of a model drug.
Narang AS; Balakrishnan A; Morrison J; Li J; Wang J; Gu H; Taylor K; Santone K; Ehrmann J; Beyer S; Lu X; Ketner R; Pizzano J; Orcutt T; Shields E; Dulac H; Aborn S; Batchelder M; Lentz K
Eur J Pharm Biopharm; 2017 Aug; 117():333-345. PubMed ID: 28455207
[TBL] [Abstract][Full Text] [Related]
18. Food, gastrointestinal pH, and models of oral drug absorption.
Abuhelwa AY; Williams DB; Upton RN; Foster DJ
Eur J Pharm Biopharm; 2017 Mar; 112():234-248. PubMed ID: 27914234
[TBL] [Abstract][Full Text] [Related]
19. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
[TBL] [Abstract][Full Text] [Related]
20. A new system for the prediction of drug absorption using a pH-controlled Caco-2 model: evaluation of pH-dependent soluble drug absorption and pH-related changes in absorption.
He X; Kadomura S; Takekuma Y; Sugawara M; Miyazaki K
J Pharm Sci; 2004 Jan; 93(1):71-7. PubMed ID: 14648637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
